Volume 385, Issue 9986, Pages (June 2015)

Slides:

Advertisements

Similar presentations

AATS Annual Meeting 2015 | Seattle, WA | April 27, 2015 Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement.

Advertisements

Martin B. Leon, M.D., Craig R. Smith, M.D., Michael Mack, M.D., D. Craig Miller, M.D., Jeffrey W. Moses, M.D., Lars G. Svensson, M.D., Ph.D., E. Murat.

Volume 389, Issue 10081, Pages (May 2017)

Volume 370, Issue 9586, Pages (August 2007)

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD)

Volume 387, Issue 10034, Pages (May 2016)

The “occasional open heart surgeon” revisited

Volume 8, Issue 10, Pages (October 2009)

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis

Emergency use of cardiopulmonary bypass in complicated transcatheter aortic valve replacement: Importance of a heart team approach Eric E. Roselli, MD,

Advising complex patients who require complex heart operations

Lars G. Svensson, MD, PhD, David H. Adams, MD, Robert O

A comprehensive review of the PARTNER trial

Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement Samir R. Kapadia,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting John V. Conte, MD, Thomas G. Gleason, MD, Jon.

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Transatlantic editorial on transcatheter aortic valve replacement

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery Jeremy J. Pereira, MB, Krzysztof Balaban, MD,

Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER.

Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, W. Brent Keeling,

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.

Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.

Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: Meta-analysis of 11,398 cases from 8 studies

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Juan A. Crestanello, MD, Richard C. Daly, MD

Transcatheter Aortic Valve Replacement Has Improved Short-Term but Similar Midterm Outcomes in Isolated Aortic Valve Replacement After Prior Coronary.

Volume 379, Issue 9812, Pages (January 2012)

The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons.

Volume 12, Issue 6, Pages (June 2013)

Appropriate patient selection or health care rationing

Multilevel data analysis: What? Why? How?

Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial Todd M.

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Long-Term Durability of Bicuspid Aortic Valve Repair

Vinod H. Thourani, MD, Hanna A

Bartosz Rylski, MD, Nimesh D. Desai, MD, PhD, Joseph E

Louis P. Perrault, MD, PhD, Alan J. Moskowitz, MD, Irving L

Volume 371, Issue 9627, Pages (May 2008)

The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement Thomas.

Volume 378, Issue 9786, Pages (July 2011)

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Simultaneous transapical transcatheter aortic and mitral valve replacement in a high-risk patient with a previous mitral bioprosthesis Adil H. Al Kindi,

Transcatheter aortic valve replacement in intermediate-risk patients

Volume 375, Issue 9719, Pages (March 2010)

Age alone should not preclude surgery: Contemporary outcomes after aortic valve replacement in nonagenarians Isaac George, MD, Halit Yerebakan, MD, Bindu.

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Vinod H. Thourani, MD, Hanna A

The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States

Kreton Mavromatis, MD, Vinod H

Off-Pump Coronary Artery Bypass Disproportionately Benefits High-Risk Patients John D. Puskas, MD, Vinod H. Thourani, MD, Patrick Kilgo, MS, William Cooper,

United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex Lars G. Svensson, MD, PhD, Todd Dewey,

Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society.

Effect of Coronary Artery Disease Extent on Contemporary Outcomes of Combined Aortic Valve Replacement and Coronary Artery Bypass Graft Surgery Zhongmin.

Commentary: When a choice is not an echo

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Presentation transcript:

Volume 385, Issue 9986, Pages 2477-2484 (June 2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial Prof Michael J Mack, MD, Prof Martin B Leon, MD, Prof Craig R Smith, MD, Prof D Craig Miller, MD, Prof Jeffrey W Moses, MD, Prof E Murat Tuzcu, MD, Prof John G Webb, MD, Prof Pamela S Douglas, MD, William N Anderson, PhD, Eugene H Blackstone, MD, Susheel K Kodali, MD, Raj R Makkar, MD, Gregory P Fontana, MD, Prof Samir Kapadia, MD, Prof Joseph Bavaria, MD, Rebecca T Hahn, MD, Prof Vinod H Thourani, MD, Vasilis Babaliaros, MD, Prof Augusto Pichard, MD, Prof Howard C Herrmann, MD, David L Brown, MD, Mathew Williams, MD, Michael J Davidson, MD, Prof Lars G Svensson, MD The Lancet Volume 385, Issue 9986, Pages 2477-2484 (June 2015) DOI: 10.1016/S0140-6736(15)60308-7 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile Eligibility was based on whether the patient would benefit equally from either treatment. If the heart team judged that the patient was not equally served by either treatment, then they were not enrolled. Lost to follow-up was declared only after contact efforts by the sites; patients had the right to withdraw at any time without giving reasons. TAVR=transcatheter aortic valve replacement. SAVR=surgical aortic valve replacement. The Lancet 2015 385, 2477-2484DOI: (10.1016/S0140-6736(15)60308-7) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Mortality and cardiovascular outcomes Kaplan-Meier analysis of all-cause death in the intention-to-treat population (A) and by landmark analysis (B); stroke or transient ischaemic attack (C); and stroke, transient ischaemic attack, or death from any cause (D). HR=hazard ratio. TAVR=transcatheter aortic valve replacement. SAVR=surgical aortic valve replacement. The Lancet 2015 385, 2477-2484DOI: (10.1016/S0140-6736(15)60308-7) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Subgroup analyses The interaction terms result from using Cox regression with a trial arm × covariate interaction term. HR=hazard ratio. TAVR=transcatheter aortic valve replacement. SAVR=surgical aortic valve replacement. STS=Society of Thoracic Surgeons Predicted Risk of Mortality. BMI=body-mass index. MR=mitral regurgitation. CABG=coronary artery bypass graft. PCI=percutaneous coronary intervention. The Lancet 2015 385, 2477-2484DOI: (10.1016/S0140-6736(15)60308-7) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 4 Echocardiographic findings Aortic valve area (A), mean gradient (B), and left ventricular mass regression (C). Points are means, bars are SDs. TAVR=transcatheter aortic valve replacement. SAVR=surgical aortic valve replacement. The Lancet 2015 385, 2477-2484DOI: (10.1016/S0140-6736(15)60308-7) Copyright © 2015 Elsevier Ltd Terms and Conditions